NCT05818553View on ClinicalTrials.gov

A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE)

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 2, 2023

Primary Completion Date

March 23, 2026

Study Completion Date

March 1, 2027

Conditions
SCN2A EncephalopathySCN8A Encephalopathy
Interventions
DRUG

PRAX-562

Once daily oral or G-tube treatment.

Trial Locations (5)

28034

RECRUITING

Praxis Research Site, Madrid

30329

ACTIVE_NOT_RECRUITING

Praxis Research Site, Atlanta

55113

RECRUITING

Praxis Research Site, Minneapolis

60611

RECRUITING

Praxis Research Site, Chicago

07601

RECRUITING

Praxis Research Site, Hackensack

Sponsors
All Listed Sponsors
lead

Praxis Precision Medicines

INDUSTRY

NCT05818553 - A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE) | Biotech Hunter | Biotech Hunter